Moderna has snagged a former Novartis manufacturing exec to oversee completion and scale-up of a $110 million manufacturing facility near Boston.

Boehringer Ingelheim saw a significant rise in sales in the first half of the year, in part from a healthy jump in its contract manufacturing operations.

Dr. Reddy's CEO GV Prasad says the generic drugmaker’s top priority is to do what is needed to get its manufacturing up to FDA expectations.

WuXi's small molecule CDMO STA is adding a drug development services operation as it builds itself into an end-to-end CDMO.

McKesson reported lower Q1 earnings a day after shareholders rejected an executive compensation plan at the company’s annual meeting held near Dallas.

Torbay Pharmaceuticals, a part of the Torbay and South Devon National Health System Foundation, opened its new $36 million manufacturing facility in Paignton,…

German drugmaker Boehringer Ingelheim will invest $217 million to upgrade and expand its Fremont, California, facility to boost production.

Endo has decided the 350 jobs it whacked from its Huntsville, Alabama, manufacturing site were not enough and will close it instead.

Supply Chain